These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9747717)

  • 1. Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation.
    Podlech J; Holtappels R; Wirtz N; Steffens HP; Reddehase MJ
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2099-104. PubMed ID: 9747717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence against a key role for transforming growth factor-beta1 in cytomegalovirus-induced bone marrow aplasia.
    Dobonici M; Podlech J; Steffens HP; Maiberger S; Reddehase MJ
    J Gen Virol; 1998 Apr; 79 ( Pt 4)():867-76. PubMed ID: 9568983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection.
    Podlech J; Holtappels R; Pahl-Seibert MF; Steffens HP; Reddehase MJ
    J Virol; 2000 Aug; 74(16):7496-507. PubMed ID: 10906203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The establishment of cytomegalovirus latency in organs is not linked to local virus production during primary infection.
    Balthesen M; Dreher L; Lucin P; Reddehase MJ
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2329-36. PubMed ID: 8077931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive transfer of cytomegalovirus-specific effector CD4+ T cells provides antiviral protection from murine CMV infection.
    Jeitziner SM; Walton SM; Torti N; Oxenius A
    Eur J Immunol; 2013 Nov; 43(11):2886-95. PubMed ID: 23921569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation from a pediatric donor with a high frequency of cytomegalovirus-specific T-cells.
    Komatsu H; Kogawa K; Nonoyama S; Inui A; Sogo T; Fujisawa T; Klenerman P
    J Med Virol; 2006 Dec; 78(12):1616-23. PubMed ID: 17063516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
    Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
    Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation.
    Lugthart G; van Ostaijen-Ten Dam MM; Jol-van der Zijde CM; van Holten TC; Kester MG; Heemskerk MH; Bredius RG; van Tol MJ; Lankester AC
    Biol Blood Marrow Transplant; 2014 May; 20(5):655-61. PubMed ID: 24462981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus infection after bone marrow transplantation in children.
    Castagnola E; Cappelli B; Erba D; Rabagliati A; Lanino E; Dini G
    Hum Immunol; 2004 May; 65(5):416-22. PubMed ID: 15172440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT.
    Hertenstein B; Hampl W; Bunjes D; Wiesneth M; Duncker C; Koszinowski U; Heimpel H; Arnold R; Mertens T
    Bone Marrow Transplant; 1995 Mar; 15(3):387-93. PubMed ID: 7599563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute GVHD results in a severe DC defect that prevents T-cell priming and leads to fulminant cytomegalovirus disease in mice.
    Wikstrom ME; Fleming P; Kuns RD; Schuster IS; Voigt V; Miller G; Clouston AD; Tey SK; Andoniou CE; Hill GR; Degli-Esposti MA
    Blood; 2015 Sep; 126(12):1503-14. PubMed ID: 26130706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
    Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
    Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delineating the role of CD4+ T cells in the activation of human cytomegalovirus-specific immune responses following immunization with Ad-gBCMVpoly vaccine: implications for vaccination of immunocompromised individuals.
    Zhong J; Khanna R
    J Gen Virol; 2010 Dec; 91(Pt 12):2994-3001. PubMed ID: 20810748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention strategies differentially modulate the impact of cytomegalovirus replication on CD8(+) T-cell differentiation in high-risk solid organ transplant patients.
    Cantisán S; Páez-Vega A; Pérez-Romero P; Montejo M; Cordero E; Gracia-Ahufinger I; Martín-Gandul C; Maruri N; Aguado R; Solana R; Torre-Cisneros J;
    Antiviral Res; 2016 Aug; 132():244-51. PubMed ID: 27378225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble recombinant CMVpp65 spanning multiple HLA alleles for reconstitution of antiviral CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation.
    Paine A; Oelke M; Tischer S; Heuft HG; Blasczyk R; Eiz-Vesper B
    J Immunother; 2010 Jan; 33(1):60-72. PubMed ID: 19952955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation.
    Shankar G; Bryson JS; Jennings CD; Morris PE; Cohen DA
    Am J Respir Cell Mol Biol; 1998 Feb; 18(2):235-42. PubMed ID: 9476911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
    Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ
    Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytopathology or immunopathology? The puzzle of cytomegalovirus pneumonitis revisited.
    Barry SM; Johnson MA; Janossy G
    Bone Marrow Transplant; 2000 Sep; 26(6):591-7. PubMed ID: 11035367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
    Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
    Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.